Description

ST GLIPTIN GM 50+1000+2 is a powerful combination anti-diabetic medicine formulated with Sitagliptin, Metformin Hydrochloride, and Glimepiride. This triple-action therapy is designed to effectively control high blood sugar levels in adults with Type 2 Diabetes Mellitus (T2DM). Each component works through a unique mechanism to improve glucose control, reduce insulin resistance, and enhance insulin secretion — thereby helping patients achieve better glycemic balance. Manufactured with advanced pharmaceutical standards, ST GLIPTIN GM 50+1000+2 helps lower the risk of diabetes-related complications such as kidney damage, heart disease, nerve issues, and vision problems. It is recommended as part of a complete diabetes management plan that includes diet control, exercise, and regular blood sugar monitoring. Uses ST GLIPTIN GM 50+1000+2 is primarily used for the management of Type 2 Diabetes Mellitus. It is prescribed to: Improve glycemic control in patients whose blood sugar levels are not adequately managed by diet, exercise, or single oral medications. Help reduce the risk of diabetic complications, including neuropathy, retinopathy, and cardiovascular issues. Support overall metabolic balance by enhancing insulin sensitivity and secretion while decreasing excess glucose production in the liver. This combination therapy provides a comprehensive approach to diabetes care, targeting multiple metabolic pathways for better blood sugar regulation. Benefits The ST GLIPTIN GM 50+1000+2 tablet offers several clinical and therapeutic benefits due to the synergistic action of its three active ingredients: 1. Sitagliptin (50 mg): Sitagliptin is a DPP-4 inhibitor that increases incretin hormone levels, which help regulate insulin release after meals. It helps the pancreas produce more insulin and lowers the amount of glucose made by the liver, improving post-meal glucose control. 2. Metformin Hydrochloride (1000 mg): Metformin is a biguanide that works by decreasing hepatic glucose production and improving insulin sensitivity. It helps the body use insulin more effectively, promoting stable glucose levels without significant risk of weight gain. 3. Glimepiride (2 mg): Glimepiride is a sulfonylurea derivative that stimulates the pancreas to release more insulin. It aids in controlling fasting and postprandial (after meal) blood sugar levels, making it effective in long-term glycemic management. Combined Benefits: Provides triple mechanism control over blood sugar levels. Reduces the risk of glycemic variability (fluctuations in blood glucose). Improves insulin sensitivity and pancreatic function. May help prevent diabetes-related cardiovascular complications. Enhances treatment adherence by combining three potent agents into one convenient tablet. Dosage The dosage of ST GLIPTIN GM 50+1000+2 should be determined by a healthcare professional based on the patient’s blood sugar level, response to treatment, and overall health condition. Recommended Dosage Guidelines: Generally taken once daily with food, preferably with breakfast or the first main meal of the day. Swallow the tablet whole with water. Do not crush, chew, or break it. It is essential to follow the prescribed schedule and not skip or double doses. Note: Always consult your doctor before making any changes to dosage or medication schedule, especially if you are taking other anti-diabetic medicines. Side Effects Like any medication, ST GLIPTIN GM 50+1000+2 may cause certain side effects, though not everyone experiences them. Common and rare side effects include: Common Side Effects: Mild hypoglycemia (low blood sugar) Headache or dizziness Nausea, vomiting, or stomach discomfort Diarrhea or abdominal pain Fatigue or weakness Serious Side Effects (Rare): Severe hypoglycemia (especially when combined with other anti-diabetics) Lactic acidosis (due to metformin accumulation — a medical emergency) Allergic reactions like rash, itching, or swelling Liver function abnormalities or jaundice Pancreatitis (inflammation of the pancreas) If any serious symptoms occur, seek immediate medical attention. Conclusion ST GLIPTIN GM 50+1000+2 is an advanced and effective combination therapy for Type 2 Diabetes Mellitus, providing comprehensive control of blood sugar levels through a multi-mechanism approach. By combining the benefits of Sitagliptin, Metformin, and Glimepiride, this medication helps improve insulin efficiency, enhance glucose metabolism, and reduce long-term diabetic risks. To achieve the best results, patients should maintain a balanced diet, regular physical activity, and routine monitoring of blood sugar. Always use this medication under the guidance of a registered medical practitioner.